HCS/SCS/SB 28 - This act provides that the anti-kickback penalties specified in Section 191.905 will not apply to certain programs established by pharmaceutical companies. These programs provide partial rebates of private health insurance copayments and coinsurance to patients with multiple sclerosis or other chronic, potentially disabling or life-threatening conditions who have been prescribed disease-managing medicines for which there are no generic equivalents.
This act allows the Missouri State Board for Pharmacy to establish the Well-being Committee to assist pharmacists who suffer from illness, substance abuse, mental illness, or physical impairments. The board will enter into contractual agreements with nonprofit corporations in order to create, support, and maintain the committee. All communications involving the licensee and the committee are confidential and not considered public records. The committee may disclose information about an impaired licensee under the following circumstances: when it is necessary to further the intervention, treatment, or rehabilitation of the licensee; the release is authorized by the licensee; the committee must make a report to the board; or the information is subject to a court order.